The Pennant Group (NASDAQ: PNTG) will likely slow down its acquisition activity during the remainder of the year and early 2022 as they work to recover from pandemic headwinds that bruised the hospice, home health and senior housing provider during the third quarter. Pennant has been aggressive on acquisitions during the past two years, including […]
LHC Group (NASDAQ: LHCG) executives today announced a slowed, albeit continued, focus on hospice growth heading into 2022. The company has been bullish on the hospice market in recent years, with hospices deals making up a little more than 60% of in cash flow set aside to further boost its M&A pipeline last quarter. Heading […]
Humana (NYSE: HUM) is currently migrating Kindred at Home’s home health services into its health care service brand, CenterWell. The company will be focused on expanding the acquired asset’s footprint in select markets in North Carolina and Virginia in 2022 as it paves the way for a hospice spin off. Humana in April completed the […]
A forthcoming deal and new hospital system partnerships stands to potentially double Contessa’s footprint through the end of this year and into 2022. Contessa is a subsidiary of Amedisys (NASDAQ: AMED), which acquired the company in June for a total consideration of $250 million. In the midst of this expansion, the company has plans to […]
Addus HomeCare Corp. (NASDAQ: ADUS) has a number of deals in its mergers and acquisition pipeline, some expected to occur in the fourth quarter. The company is leaning its M&A activity towards personal care and home health, but hospice transactions may be in the cards as they work to build density in markets where they […]
COVID-19 headwinds continue to pose obstacles for hospice providers nationwide, including VITAS Healthcare, a subsidiary of Chemed Corp. (NYSE: CHEM). The company has recently seen drops in its patient census due to pandemic-related disruption, and maintaining staffing levels remains a top priority amid industry-wide shortages. During the third quarter admissions exceeded discharges for the first […]
A forthcoming hospice and home health spin off company from Encompass Health (NYSE: ENC) will be a publicly traded entity. Encompass announced last December that a strategic repositioning of the segment was in the cards. The transaction is expected to take place during the first half of 2022. To ready themselves for a separation, Encompass […]
The Pennant Group’s (NASDAQ: PNTG) acquisition strategy is fueling growth in both the near- and long-term for the company’s home health and hospice segment. Pennant has been very active in the M&A market during the past two years, with additional transactions waiting in its pipeline. Pennant, which owns and operates hospice provider Cornerstone Healthcare, was […]
Amedisys (NASDAQ: AMED) has been among the many home health and hospice providers taking financial and operational hits as the coronavirus pandemic continues its spread. Despite facing headwinds, the company remains steadfast in its position on hospice as it seeks to further build up its presence in the market. Another recent uptick of cases stemming […]
LHC Group Inc. (NASDAQ: LHCG) leadership revealed in an earnings call Thursday morning that its merger-and-acquisition activity has hit an all-time high this year. Additionally, hospice deals currently make up just above 60% of the $400 million the company currently has set aside to further boost its M&A pipeline as 2021 unfolds. Hospice will remain […]
